|
Index of reports
> Cases resulting in life threatening events (5)
> Cases with Pneumonia (4)
Below is the selection of adverse event reports related to Symmetrel (Amantadine) that includes cases resulting in life threatening events where reactions include pneumonia.
Adverse event in male receiving Symmetrel (Amantadine)
Reported by a physician from Japan on 2007-02-02
Patient: male, weighing 66.3 kg (145.9 pounds)
Adverse reactions / side effects: Pneumonia, Rhabdomyolysis, Cerebral Infarction
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
BI-Sifrol Tablets
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2006-04-10
Artane
Administration route: Oral
Indication: Parkinson's Disease
Start date: 1991-01-01
Symmetrel
Administration route: Oral
Indication: Parkinson's Disease
Start date: 1991-01-01
Paxil
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2004-06-08
Other drugs received by patient: Meilax; Mucosta
Adverse event in male receiving Symmetrel (Amantadine)
Reported by a physician from Japan on 2007-01-30
Patient: male, weighing 66.3 kg (145.9 pounds)
Adverse reactions / side effects: Pneumonia, Rhabdomyolysis, Cerebral Infarction
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
BI-Sifrol Tablets
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2006-04-10
Artane
Administration route: Oral
Indication: Parkinson's Disease
Start date: 1991-01-01
Symmetrel
Administration route: Oral
Indication: Parkinson's Disease
Start date: 1991-01-01
Paxil
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2004-06-08
Other drugs received by patient: Meilax; Mucosta
Adverse event in male receiving Symmetrel (Amantadine)
Reported by a physician from Japan on 2007-01-22
Patient: male, weighing 66.3 kg (145.9 pounds)
Adverse reactions / side effects: Pneumonia, Rhabdomyolysis, Cerebral Infarction
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
BI-Sifrol Tablets
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2006-04-10
Artane
Administration route: Oral
Indication: Parkinson's Disease
Start date: 1991-01-01
Symmetrel
Administration route: Oral
Indication: Parkinson's Disease
Start date: 1991-01-01
Paxil
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2004-06-08
Other drugs received by patient: Meilax; Mucosta
Adverse event in male receiving Symmetrel (Amantadine)
Reported by a physician from Japan on 2007-01-12
Patient: male, weighing 66.3 kg (145.9 pounds)
Adverse reactions / side effects: Pneumonia, Rhabdomyolysis, Cerebral Infarction
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
BI-Sifrol Tablets
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2006-04-10
Artane
Administration route: Oral
Indication: Parkinson's Disease
Start date: 1991-01-01
Symmetrel
Administration route: Oral
Indication: Parkinson's Disease
Start date: 1991-01-01
Paxil
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2004-06-08
Other drugs received by patient: Meilax; Mucosta
|
